Deborah Ascheim
Fortune : 2 524 $ au 31/07/2026
Fortune : 2 524 $ au 31/07/2026
Deborah D.
Ascheim is currently Director at Longeveron, Inc. since 2026 and Chief Medical Officer-Fractional at Rejuvenate Bio, Inc. Former roles include Vice Chairman at Physicians for Human Rights and Chief Medical Officer at Capricor Therapeutics, Inc. from 2015 to 2018.
Education includes undergraduate studies at Wellesley College and a doctorate from New York University School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/08/2026 | 3 600 ( 0,01% ) | 2 524 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LONGEVERON INC. | Directeur/Membre du Conseil | 01/07/2026 |
Rejuvenate Bio, Inc.
Rejuvenate Bio, Inc. BiotechnologyHealth Technology Develops novel gene therapies for dogs | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/11/2018 |
Physicians for Human Rights
Physicians for Human Rights Miscellaneous Commercial ServicesCommercial Services Protects human health by protecting human rights | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Wellesley College
Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Physicians for Human Rights
Physicians for Human Rights Miscellaneous Commercial ServicesCommercial Services Protects human health by protecting human rights | Commercial Services |
Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative products for the treatment of cardiovascular diseases | Health Technology |
New York University School of Medicine
New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longeveron, Inc.
Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Rejuvenate Bio, Inc.
Rejuvenate Bio, Inc. BiotechnologyHealth Technology Develops novel gene therapies for dogs | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national